These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 32666706)
61. Bergua C; Chiavelli H; Allenbach Y; Arouche-Delaperche L; Arnoult C; Bourdenet G; Jean L; Zoubairi R; Guerout N; Mahler M; Benveniste O; Drouot L; Boyer O Ann Rheum Dis; 2019 Jan; 78(1):131-139. PubMed ID: 30309969 [TBL] [Abstract][Full Text] [Related]
62. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies. Julien S; Challier I; Malleter M; Jouen F; Drouot L; Boyer O Antibodies (Basel); 2024 Feb; 13(1):. PubMed ID: 38390873 [TBL] [Abstract][Full Text] [Related]
63. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption. Parikh P; Tavee J; Soltanzadeh P; Mammen AL; McKeever P; Li Y Muscle Nerve; 2018 Jun; 57(6):E135-E136. PubMed ID: 29346706 [No Abstract] [Full Text] [Related]
64. A Rare Case of Anti-HMGCR and Anti-SRP-Positive Immune-Mediated Necrotizing Myopathy. Khan N; Kazmi Z Qatar Med J; 2022; 2022(1):6. PubMed ID: 35261909 [TBL] [Abstract][Full Text] [Related]
65. Autoimmune necrotising myopathy and HMGCR antibodies. Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058 [TBL] [Abstract][Full Text] [Related]
66. Initial seronegative immune-mediated necrotising myopathy with subsequent anti-HMGCR antibody development and response to rituximab: case report. Thomas R; Yeoh SA; Berkeley R; Woods A; Stevens M; Marino S; Radunovic A BMC Rheumatol; 2020; 4():29. PubMed ID: 32613157 [TBL] [Abstract][Full Text] [Related]
67. Statin-naïve anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibody-positive necrotizing myopathy with heliotropic pseudoangioedema. Ortiz C; Candela B; Bowers L; Cai E; English JC JAAD Case Rep; 2022 Mar; 21():198-200. PubMed ID: 35284610 [No Abstract] [Full Text] [Related]
68. Case report: Diagnostic clues for anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy in pediatric patients. Watanuki K; Koga H Front Pediatr; 2023; 11():1102539. PubMed ID: 36994439 [TBL] [Abstract][Full Text] [Related]
69. Adaptive immune response to therapy in hmgcr autoantibody myopathy. Yi JS; Russo MA; Weinhold KJ; Guptill JT Muscle Nerve; 2016 Feb; 53(2):313-7. PubMed ID: 26492512 [TBL] [Abstract][Full Text] [Related]
70. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies. Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107 [TBL] [Abstract][Full Text] [Related]
71. Rheumatoid Arthritis Associated With Anti-Signal Recognition Particle Immune-Mediated Necrotizing Myopathy: A Case Report. Belkhribchia MR; Lobrinus JA; Semlil L; Chauveau N; Ajrinija A; Egervari K; Ennhaili ZE J Investig Med High Impact Case Rep; 2024; 12():23247096241231646. PubMed ID: 38353222 [TBL] [Abstract][Full Text] [Related]
72. Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy. Kubota A; Shimizu J; Unuma A; Maeda M; Shirota Y; Kadoya M; Uchio N; Sakiyama Y; Arai N; Shiio Y; Uesaka Y; Hashida H; Iwata NK; Goto J; Nakashima R; Mimori T; Toda T Neuromuscul Disord; 2022 Jan; 32(1):25-32. PubMed ID: 34916121 [TBL] [Abstract][Full Text] [Related]
73. Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report. Lim D; Landon-Cardinal O; Ellezam B; Belisle A; Genois A; Sirois J; Bourré-Tessier J SAGE Open Med Case Rep; 2020; 8():2050313X20984120. PubMed ID: 33447390 [TBL] [Abstract][Full Text] [Related]